MeSH D008105 - biliary liver cirrhosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Ursodiol | Actigall | 1987-12-31 | |||
| Ursodiol | Ursodiol | 2000-05-25 | ||||
| Novast Laboratories | Colchicine, Probenecid | Probenecid Colchicine | 2008-05-13 | |||
| Glenmark Pharmaceuticals | Ursodiol | Ursodiol | 2011-07-12 | |||
| Mylan | Colchicine | Colchicine | 2019-09-16 | |||
| Ursodiol | Ursodiol | 2010-02-17 | ||||
| Sandoz | Colchicine, Probenecid | Probenecid Colchicine | 1982-01-01 | |||
| Merck & Co | Colchicine, Probenecid | Colbenemid | 1982-01-01 | |||
| Allergan | Ursodiol | Urso | 1997-12-10 | |||
| Colchicine, Probenecid | Col-probenecid | 1982-01-01 | ||||
| Colchicine | Colchicine | 2019-07-31 | ||||
| Colchicine, Probenecid | Proben-c | 1982-01-01 | ||||
| Colchicine, Probenecid | Probenecid W/ Colchicine | 1982-01-01 |
1
2
3
4
>
Clinical Trials
Historical Success Rate
Phase 1
73%8/11
Phase 2
42%10/24
Phase 3
37%7/19
Approved: 4Overall Success rate: 11%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use